X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Bispecific Cancer Drugs, Gene Therapy Advances At Next ASH

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    $2 Million Gene Therapy Might Become The Standard In The US

    $2 Million Gene Therapy Might Become The Standard In The US

    Cancer Medicine Prices Jump 53% In Five Years In The U.S

    Food And Drug Administration User Fee Has Been Reauthorized

    Cancer Clinical Trials Get A Brand New Platform In Melbourne

    Report Indicates UK £62bn Behind In Global R&D Investment

    Wall Street Cautiously Optimistic After Gene Therapy Deals

    RoboCap: A Robotic Capsule to Improve Gut Drug Delivery

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Bispecific Cancer Drugs, Gene Therapy Advances At Next ASH

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    $2 Million Gene Therapy Might Become The Standard In The US

    $2 Million Gene Therapy Might Become The Standard In The US

    Cancer Medicine Prices Jump 53% In Five Years In The U.S

    Food And Drug Administration User Fee Has Been Reauthorized

    Cancer Clinical Trials Get A Brand New Platform In Melbourne

    Report Indicates UK £62bn Behind In Global R&D Investment

    Wall Street Cautiously Optimistic After Gene Therapy Deals

    RoboCap: A Robotic Capsule to Improve Gut Drug Delivery

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Drug Development Research & Development

The Maestro Pro and Maestro Edge Platforms Introduced By Axion BioSytems

Yuvraj_pawp by Yuvraj_pawp
12th September 2017
in Research & Development

Axion BioSystems, the global leader in microelectrode array (MEA) technology, introduces the next generation of MEA platforms, Maestro Pro and Maestro Edge.

Excitable cells play a fundamental role in life, from heart beats to brain function. Maestro MEA systems capture live-cell activity from electroactive cells in real-time, allowing scientists to recreate complex human functions in culture dishes. As a result, scientists can now conduct research that spans from rapid stem cell development to advanced drug screening.
Built on Axion’s latest chip technology, BioCore v4, the next generation Maestro MEA systems make it even easier to perform measurements from excitable cells in your own lab. With “one button setup,” the cell environment automatically adjusts on plate docking, and plate usage is automatically logged for convenient experiment tracking. Both Maestro Pro and Edge run Axion’s most advanced data acquisition and analysis software, AxIS Navigator.

“The explosion of research related to stem cell models has driven the rapid adoption of Maestro MEA systems,” stated Jim Ross, Axion CTO. “Sophisticated data does not have to be tedious and complicated. Maestro Pro and Edge have made the study of excitable cells accessible to all biologists, setting a new standard for measuring electroactive cell function.”


“Our team has been actively using Axion’s Maestro since 2013 to explore the neuronal networks associated with epilepsy with outstanding results,” said Mike Boland, Assistant Professor at Columbia University’s Institute for Genomic Medicine. “I am excited to see the introduction of Axion’s new generation of Maestros. With universities and companies rapidly integrating human iPSC differentiation technology into their labs, there is a growing need for a simple, reliable, and cost-effective tool to track and analyze complex cell models. “


“The Maestro MEA system is the world’s leading MEA platform, and has been our flagship product for the last four years,” stated Tom O’Brien, Axion BioSystems President, and CEO. “Today, Axion’s innovation moves the field forward again. The Maestro Pro is the world’s most advanced MEA platform for the highest throughput applications. The Maestro Edge now allows researchers and clinicians to access Maestro-quality data but at a price that addresses the budget constraints of academic labs.”


The Maestro Pro’s cutting-edge platform has an integrated touch screen for tracking experimental progress, and is capable of recording from 768 electrodes simultaneously. Its companion system, Maestro Edge, is an affordable extension to the Maestro product family, featuring 384-recording electrodes. This new, lower cost instrument will open up Axion’s MEA technology to many more labs. Any scientist can now quickly and easily measure electrical network behavior in live cells in multiwell plates. Now there is nothing to stop you from exploring life’s circuitry.

Previous Post

Iovance Biotherapeutics Partners with TrakCel for Personalized Patient Product Management

Next Post

Reata Pharmaceuticals, Inc. Receives Orphan Drug Designation for Omaveloxolone for the Treatment of Malignant Melanoma

Related Posts

News

Cancer Medicine Prices Jump 53% In Five Years In The U.S

3rd November 2022
News

Report Indicates UK £62bn Behind In Global R&D Investment

3rd November 2022
News

Once More, M&As In Biotechechnology Industry Are Thriving

2nd November 2022
DNA
News

Ancient Viral DNA Guards Against Infections In Human Genome

31st October 2022
News

Omicron Subvariants Withstand Essential Antibody Treatments

31st October 2022
As Medical Uses Cope Up, Genomic Studies Reap Scale Benefits
News

Research And Development In UK Falls Behind Other Nations

28th October 2022
Next Post

Reata Pharmaceuticals, Inc. Receives Orphan Drug Designation for Omaveloxolone for the Treatment of Malignant Melanoma

Latest News

Clinical Trials

Bispecific Cancer Drugs, Gene Therapy Advances At Next ASH

8th November 2022
Facilities & Operation

India Seeks Better Pharma Market Access In The UK: Official

8th November 2022
First Virtual Drug Study Tests 2 Likely Alzheimer Therapies
Clinical Trials

First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

7th November 2022
Facilities & Operation

CPhI Pharma Index Shows Unprecedented Global Pharma Optimism

5th November 2022
$2 Million Gene Therapy Might Become The Standard In The US
Drug Development

$2 Million Gene Therapy Might Become The Standard In The US

5th November 2022
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In